TLE1/2/3/4 Polyclonal Conjugated Antibody |
|||
| C46729 | SAB | 100ul | 476.4 EUR |
Anti-TLE1/2/3/4 Antibody |
|||
| A02460 | BosterBio | 100ul | 476.4 EUR |
|
Description: Rabbit Polyclonal Antibody for TLE1/2/3/4 Antibody (TLE1) detection.tested for IHC, WB in Human, Mouse, Rat. |
|||
Anti-TLE1/2/3/4 antibody |
|||
| STJ98577 | St John's Laboratory | 200 µl | 236.4 EUR |
|
Description: Rabbit polyclonal to TLE1/2/3/4. |
|||
Recombinant TMPRSS2 Protein, Partial |
|||
| E80017 | EpiGentek |
|
|
Recombinant Novel Coronavirus Spike Glycoprotein(S), Partial |
|||
| E80018 | EpiGentek |
|
|
EpiQuik Dnmt1 Assay Kit |
|||
| P-3011 | EpiGentek |
|
|
EpiQuik Dnmt3A Assay Kit |
|||
| P-3012 | EpiGentek |
|
|
EpiQuik Dnmt3B Assay Kit |
|||
| P-3013 | EpiGentek |
|
|
Rabbit Complement 3-4 WK (100-mL) |
|||
| 31061-3 | Pel-Freez | 100mL | 1322.98 EUR |
TLE1 Rabbit pAb |
|||
| A13360-100ul | Abclonal | 100 ul | 369.6 EUR |
TLE1 Rabbit pAb |
|||
| A13360-200ul | Abclonal | 200 ul | 550.8 EUR |
TLE1 Rabbit pAb |
|||
| A13360-20ul | Abclonal | 20 ul | 219.6 EUR |
TLE1 Rabbit pAb |
|||
| A13360-50ul | Abclonal | 50 ul | 267.6 EUR |
TLE1 Rabbit mAb |
|||
| A3528-100ul | Abclonal | 100 ul | 492 EUR |
TLE1 Rabbit mAb |
|||
| A3528-200ul | Abclonal | 200 ul | 685.2 EUR |
TLE1 Rabbit mAb |
|||
| A3528-20ul | Abclonal | 20 ul | 265.2 EUR |
TLE1 Rabbit mAb |
|||
| A3528-50ul | Abclonal | 50 ul | 344.4 EUR |
TLE1 Rabbit pAb |
|||
| A5501-100ul | Abclonal | 100 ul | 369.6 EUR |
TLE1 Rabbit pAb |
|||
| A5501-200ul | Abclonal | 200 ul | 550.8 EUR |
TLE1 Rabbit pAb |
|||
| A5501-20ul | Abclonal | 20 ul | 219.6 EUR |
TLE1 Rabbit pAb |
|||
| A5501-50ul | Abclonal | 50 ul | 267.6 EUR |
EpiQuik Superoxide Dismutase Activity/Inhibition Assay Kit (Colorimetric) |
|||
| OP-0001 | EpiGentek |
|
|
CytoX-Violet Cell Proliferation/Cytotoxicity Assay Kit |
|||
| OP-0005 | EpiGentek |
|
|
EpiQuik Chromatin Immunoprecipitation (ChIP) Kit |
|||
| P-2002 | EpiGentek |
|
|
EpiQuik Tissue Chromatin Immunoprecipitation (ChIP) Kit |
|||
| P-2003 | EpiGentek |
|
|
Anti-Cytokeratin 4 (CK-4) Rabbit Monoclonal Antibody, Clone#RM355 |
|||
| M07410-2 | BosterBio | 100uL | 462 EUR |
|
Description: Anti-Cytokeratin 4 (CK-4) Rabbit Monoclonal Antibody, Clone#RM355 tested in WB, IHC, reactive to Human |
|||
Nori® Rabbit IL-4 ELISA Kit- 2 Plates |
|||
| GR144033-2 | Genorise Scientific | 2 x 96-well | 998.4 EUR |
TLE1 Antibody |
|||
| DF7380 | Affbiotech | 200ul | 420 EUR |
TLE1 Antibody |
|||
| 1-CSB-PA717264ESR1HU | Cusabio |
|
|
|
Description: A polyclonal antibody against TLE1. Recognizes TLE1 from Human. This antibody is Unconjugated. Tested in the following application: ELISA |
|||
TLE1 Antibody |
|||
| 1-CSB-PA023585GA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against TLE1. Recognizes TLE1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA |
|||
TLE1 antibody |
|||
| 70R-20844 | Fitzgerald | 50 ul | 522 EUR |
|
Description: Rabbit polyclonal TLE1 antibody |
|||
TLE1 antibody |
|||
| 70R-7915 | Fitzgerald | 50 ug | 560.4 EUR |
|
Description: Affinity purified rabbit polyclonal TLE1 antibody |
|||
TLE1 Antibody |
|||
| 32891-100ul | SAB | 100ul | 302.4 EUR |
TLE1 Antibody |
|||
| ABD7380 | Lifescience Market | 100 ug | 525.6 EUR |
TLE1 Antibody |
|||
| F52972-0.08ML | NSJ Bioreagents | 0.08 ml | 165 EUR |
TLE1 Antibody |
|||
| F52972-0.4ML | NSJ Bioreagents | 0.4 ml | 379 EUR |
TLE1 Antibody |
|||
| F52994-0.08ML | NSJ Bioreagents | 0.08 ml | 165 EUR |
TLE1 Antibody |
|||
| F52994-0.4ML | NSJ Bioreagents | 0.4 ml | 379 EUR |
TLE1 Antibody |
|||
| F40324-0.08ML | NSJ Bioreagents | 0.08 ml | 165 EUR |
TLE1 Antibody |
|||
| F40324-0.4ML | NSJ Bioreagents | 0.4 ml | 379 EUR |
TLE1 Antibody |
|||
| V3890-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
|
Description: Transcriptional corepressor that binds to a number of transcription factors. Inhibits NF-kappa-B-regulated gene expression. Inhibits the transcriptional activation mediated by FOXA2, and by CTNNB1 and TCF family members in Wnt signaling. The effects of full-length TLE family members may be modulated by association with dominant-negative AES. Unusual function as coactivator for ESRRG. [UniProt] |
|||
TLE1 Antibody |
|||
| V3890-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
|
Description: Transcriptional corepressor that binds to a number of transcription factors. Inhibits NF-kappa-B-regulated gene expression. Inhibits the transcriptional activation mediated by FOXA2, and by CTNNB1 and TCF family members in Wnt signaling. The effects of full-length TLE family members may be modulated by association with dominant-negative AES. Unusual function as coactivator for ESRRG. [UniProt] |
|||
TLE1 Antibody |
|||
| V3890SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
|
Description: Transcriptional corepressor that binds to a number of transcription factors. Inhibits NF-kappa-B-regulated gene expression. Inhibits the transcriptional activation mediated by FOXA2, and by CTNNB1 and TCF family members in Wnt signaling. The effects of full-length TLE family members may be modulated by association with dominant-negative AES. Unusual function as coactivator for ESRRG. [UniProt] |
|||
TLE1 Antibody |
|||
| V3924-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
|
Description: Key players in the Notch pathway are the TLE genes, which are human homologs of the Drosophila groucho gene. Groucho is a transcriptional repressor that plays a key role in neurogenesis, segmentation and sex determination. Transducin-like enhancer protein 1 (TLE1) is a protein that is encoded by the TLE1 gene and is involved in control of hematopoiesis, neuronal, and terminal epithelial differentiation. Positive immunohistochemical nuclear staining with anti-TLE-1 has been shown to be a useful addition to an IHC panel when differentiating synovial sarcoma from other soft tissue malignancies. |
|||
TLE1 Antibody |
|||
| V3924-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
|
Description: Key players in the Notch pathway are the TLE genes, which are human homologs of the Drosophila groucho gene. Groucho is a transcriptional repressor that plays a key role in neurogenesis, segmentation and sex determination. Transducin-like enhancer protein 1 (TLE1) is a protein that is encoded by the TLE1 gene and is involved in control of hematopoiesis, neuronal, and terminal epithelial differentiation. Positive immunohistochemical nuclear staining with anti-TLE-1 has been shown to be a useful addition to an IHC panel when differentiating synovial sarcoma from other soft tissue malignancies. |
|||
TLE1 Antibody |
|||
| V3924SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
|
Description: Key players in the Notch pathway are the TLE genes, which are human homologs of the Drosophila groucho gene. Groucho is a transcriptional repressor that plays a key role in neurogenesis, segmentation and sex determination. Transducin-like enhancer protein 1 (TLE1) is a protein that is encoded by the TLE1 gene and is involved in control of hematopoiesis, neuronal, and terminal epithelial differentiation. Positive immunohistochemical nuclear staining with anti-TLE-1 has been shown to be a useful addition to an IHC panel when differentiating synovial sarcoma from other soft tissue malignancies. |
|||
TLE1 Antibody |
|||
| V3925-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
|
Description: Key players in the Notch pathway are the TLE genes, which are human homologs of the Drosophila groucho gene. Groucho is a transcriptional repressor that plays a key role in neurogenesis, segmentation and sex determination. Transducin-like enhancer protein 1 (TLE1) is a protein that is encoded by the TLE1 gene and is involved in control of hematopoiesis, neuronal, and terminal epithelial differentiation. Positive immunohistochemical nuclear staining with anti-TLE-1 has been shown to be a useful addition to an IHC panel when differentiating synovial sarcoma from other soft tissue malignancies. |
|||
TLE1 Antibody |
|||
| V3925-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
|
Description: Key players in the Notch pathway are the TLE genes, which are human homologs of the Drosophila groucho gene. Groucho is a transcriptional repressor that plays a key role in neurogenesis, segmentation and sex determination. Transducin-like enhancer protein 1 (TLE1) is a protein that is encoded by the TLE1 gene and is involved in control of hematopoiesis, neuronal, and terminal epithelial differentiation. Positive immunohistochemical nuclear staining with anti-TLE-1 has been shown to be a useful addition to an IHC panel when differentiating synovial sarcoma from other soft tissue malignancies. |
|||
TLE1 Antibody |
|||
| V3925SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
|
Description: Key players in the Notch pathway are the TLE genes, which are human homologs of the Drosophila groucho gene. Groucho is a transcriptional repressor that plays a key role in neurogenesis, segmentation and sex determination. Transducin-like enhancer protein 1 (TLE1) is a protein that is encoded by the TLE1 gene and is involved in control of hematopoiesis, neuronal, and terminal epithelial differentiation. Positive immunohistochemical nuclear staining with anti-TLE-1 has been shown to be a useful addition to an IHC panel when differentiating synovial sarcoma from other soft tissue malignancies. |
|||
TLE1 Antibody |
|||
| V3926-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
|
Description: Key players in the Notch pathway are the TLE genes, which are human homologs of the Drosophila groucho gene. Groucho is a transcriptional repressor that plays a key role in neurogenesis, segmentation and sex determination. Transducin-like enhancer protein 1 (TLE1) is a protein that is encoded by the TLE1 gene and is involved in control of hematopoiesis, neuronal, and terminal epithelial differentiation. Positive immunohistochemical nuclear staining with anti-TLE-1 has been shown to be a useful addition to an IHC panel when differentiating synovial sarcoma from other soft tissue malignancies. |
|||
TLE1 Antibody |
|||
| V3926-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
|
Description: Key players in the Notch pathway are the TLE genes, which are human homologs of the Drosophila groucho gene. Groucho is a transcriptional repressor that plays a key role in neurogenesis, segmentation and sex determination. Transducin-like enhancer protein 1 (TLE1) is a protein that is encoded by the TLE1 gene and is involved in control of hematopoiesis, neuronal, and terminal epithelial differentiation. Positive immunohistochemical nuclear staining with anti-TLE-1 has been shown to be a useful addition to an IHC panel when differentiating synovial sarcoma from other soft tissue malignancies. |
|||
TLE1 Antibody |
|||
| V3926SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
|
Description: Key players in the Notch pathway are the TLE genes, which are human homologs of the Drosophila groucho gene. Groucho is a transcriptional repressor that plays a key role in neurogenesis, segmentation and sex determination. Transducin-like enhancer protein 1 (TLE1) is a protein that is encoded by the TLE1 gene and is involved in control of hematopoiesis, neuronal, and terminal epithelial differentiation. Positive immunohistochemical nuclear staining with anti-TLE-1 has been shown to be a useful addition to an IHC panel when differentiating synovial sarcoma from other soft tissue malignancies. |
|||
TLE1 Antibody |
|||
| V7357-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
|
Description: Key players in the Notch pathway are the TLE genes, which are human homologs of the Drosophila groucho gene. Groucho is a transcriptional repressor that plays a key role in neurogenesis, segmentation and sex determination. Transducin-like enhancer protein 1 (TLE1) is a protein that is encoded by the TLE1 gene and is involved in control of hematopoiesis, neuronal, and terminal epithelial differentiation. Positive immunohistochemical nuclear staining with anti-TLE-1 has been shown to be a useful addition to an IHC panel when differentiating synovial sarcoma from other soft tissue malignancies. |
|||
TLE1 Antibody |
|||
| V7357-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
|
Description: Key players in the Notch pathway are the TLE genes, which are human homologs of the Drosophila groucho gene. Groucho is a transcriptional repressor that plays a key role in neurogenesis, segmentation and sex determination. Transducin-like enhancer protein 1 (TLE1) is a protein that is encoded by the TLE1 gene and is involved in control of hematopoiesis, neuronal, and terminal epithelial differentiation. Positive immunohistochemical nuclear staining with anti-TLE-1 has been shown to be a useful addition to an IHC panel when differentiating synovial sarcoma from other soft tissue malignancies. |
|||
TLE1 Antibody |
|||
| V7357SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
|
Description: Key players in the Notch pathway are the TLE genes, which are human homologs of the Drosophila groucho gene. Groucho is a transcriptional repressor that plays a key role in neurogenesis, segmentation and sex determination. Transducin-like enhancer protein 1 (TLE1) is a protein that is encoded by the TLE1 gene and is involved in control of hematopoiesis, neuronal, and terminal epithelial differentiation. Positive immunohistochemical nuclear staining with anti-TLE-1 has been shown to be a useful addition to an IHC panel when differentiating synovial sarcoma from other soft tissue malignancies. |
|||
TLE1 Antibody |
|||
| V7462-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
|
Description: Transcriptional corepressor that binds to a number of transcription factors. Inhibits NF-kappa-B-regulated gene expression. Inhibits the transcriptional activation mediated by FOXA2, and by CTNNB1 and TCF family members in Wnt signaling. The effects of full-length TLE family members may be modulated by association with dominant-negative AES. Unusual function as coactivator for ESRRG. [UniProt] |
|||
TLE1 Antibody |
|||
| V7462-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
|
Description: Transcriptional corepressor that binds to a number of transcription factors. Inhibits NF-kappa-B-regulated gene expression. Inhibits the transcriptional activation mediated by FOXA2, and by CTNNB1 and TCF family members in Wnt signaling. The effects of full-length TLE family members may be modulated by association with dominant-negative AES. Unusual function as coactivator for ESRRG. [UniProt] |
|||
TLE1 Antibody |
|||
| V7462IHC-7ML | NSJ Bioreagents | 7 ml | 499 EUR |
|
Description: Transcriptional corepressor that binds to a number of transcription factors. Inhibits NF-kappa-B-regulated gene expression. Inhibits the transcriptional activation mediated by FOXA2, and by CTNNB1 and TCF family members in Wnt signaling. The effects of full-length TLE family members may be modulated by association with dominant-negative AES. Unusual function as coactivator for ESRRG. [UniProt] |
|||
TLE1 Antibody |
|||
| V7462SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
|
Description: Transcriptional corepressor that binds to a number of transcription factors. Inhibits NF-kappa-B-regulated gene expression. Inhibits the transcriptional activation mediated by FOXA2, and by CTNNB1 and TCF family members in Wnt signaling. The effects of full-length TLE family members may be modulated by association with dominant-negative AES. Unusual function as coactivator for ESRRG. [UniProt] |
|||
Rabbit Polyclonal Antibody to Human Topoisomerase IIb |
|||
| TG2010-3 | TopoGen | 250 units | 496.8 EUR |
Polyclonal TLE1 Antibody (N-term) |
|||
| AMM08213G | Leading Biology | 0.1ml | 580.8 EUR |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human TLE1 (N-term). This antibody is tested and proven to work in the following applications: |
|||
Polyclonal TLE1 Antibody (N-term) |
|||
| AMM08214G | Leading Biology | 0.1ml | 580.8 EUR |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human TLE1 (N-term). This antibody is tested and proven to work in the following applications: |
|||
Rabbit Polyclonal Antibody to Human Topoisomerase IIIb |
|||
| TG2010-4 | TopoGen | 250 units | 456 EUR |
Anti-14-3-3 alpha + beta Rabbit Monoclonal Antibody |
|||
| M02431-3 | BosterBio | 100ug/vial | 476.4 EUR |
|
Description: Rabbit Monoclonal 14-3-3 alpha + beta Antibody. Validated in Flow Cytometry, IP, IF, IHC, ICC, WB and tested in Human, Mouse, Rat. |
|||
Anti-active Caspase-3 Rabbit Monoclonal Antibody |
|||
| M00334-3 | BosterBio | 100ug/vial | 476.4 EUR |
|
Description: Anti-active Caspase-3 Rabbit Monoclonal Antibody tested for IF, IHC, ICC, WB in Human |
|||
Anti-Bcl-2 Rabbit Monoclonal Antibody |
|||
| M00040-2 | BosterBio | 100ug/vial | 476.4 EUR |
|
Description: Rabbit Monoclonal Bcl-2 Antibody. Validated in IF, WB and tested in Human, Mouse. |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2051) Antibody |
|||
| BNC942051-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2051), CF594 conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2051) Antibody |
|||
| BNC942051-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2051), CF594 conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2062) Antibody |
|||
| BNC942062-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2062), CF594 conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2062) Antibody |
|||
| BNC942062-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2062), CF594 conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2085) Antibody |
|||
| BNC942085-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2085), CF594 conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2085) Antibody |
|||
| BNC942085-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2085), CF594 conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2946R) Antibody |
|||
| BNC942946-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2946R), CF594 conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2946R) Antibody |
|||
| BNC942946-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2946R), CF594 conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2051) Antibody |
|||
| BNCA2051-250 | Biotium | 250uL | 472.8 EUR |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2051), APC conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2062) Antibody |
|||
| BNCA2062-250 | Biotium | 250uL | 472.8 EUR |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2062), APC conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2085) Antibody |
|||
| BNCA2085-250 | Biotium | 250uL | 472.8 EUR |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2085), APC conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2946R) Antibody |
|||
| BNCA2946-250 | Biotium | 250uL | 472.8 EUR |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2946R), APC conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2051) Antibody |
|||
| BNC552051-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2051), CF555 conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2051) Antibody |
|||
| BNC552051-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2051), CF555 conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2062) Antibody |
|||
| BNC552062-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2062), CF555 conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2062) Antibody |
|||
| BNC552062-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2062), CF555 conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2085) Antibody |
|||
| BNC552085-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2085), CF555 conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2085) Antibody |
|||
| BNC552085-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2085), CF555 conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2946R) Antibody |
|||
| BNC552946-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2946R), CF555 conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2946R) Antibody |
|||
| BNC552946-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2946R), CF555 conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2051) Antibody |
|||
| BNC612051-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2051), CF660R conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2051) Antibody |
|||
| BNC612051-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2051), CF660R conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2062) Antibody |
|||
| BNC612062-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2062), CF660R conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2062) Antibody |
|||
| BNC612062-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2062), CF660R conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2085) Antibody |
|||
| BNC612085-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2085), CF660R conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2085) Antibody |
|||
| BNC612085-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2085), CF660R conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2946R) Antibody |
|||
| BNC612946-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2946R), CF660R conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2946R) Antibody |
|||
| BNC612946-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2946R), CF660R conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2051) Antibody |
|||
| BNCP2051-250 | Biotium | 250uL | 472.8 EUR |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2051), PerCP conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2062) Antibody |
|||
| BNCP2062-250 | Biotium | 250uL | 472.8 EUR |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2062), PerCP conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2085) Antibody |
|||
| BNCP2085-250 | Biotium | 250uL | 472.8 EUR |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2085), PerCP conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2946R) Antibody |
|||
| BNCP2946-250 | Biotium | 250uL | 472.8 EUR |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2946R), PerCP conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2051) Antibody |
|||
| BNCR2051-250 | Biotium | 250uL | 472.8 EUR |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2051), RPE conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2062) Antibody |
|||
| BNCR2062-250 | Biotium | 250uL | 472.8 EUR |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2062), RPE conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2085) Antibody |
|||
| BNCR2085-250 | Biotium | 250uL | 472.8 EUR |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2085), RPE conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2946R) Antibody |
|||
| BNCR2946-250 | Biotium | 250uL | 472.8 EUR |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2946R), RPE conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2051) Antibody |
|||
| BNC402051-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2051), CF640R conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2051) Antibody |
|||
| BNC402051-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2051), CF640R conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2062) Antibody |
|||
| BNC402062-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2062), CF640R conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2062) Antibody |
|||
| BNC402062-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2062), CF640R conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2085) Antibody |
|||
| BNC402085-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2085), CF640R conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2085) Antibody |
|||
| BNC402085-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2085), CF640R conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2946R) Antibody |
|||
| BNC402946-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2946R), CF640R conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2946R) Antibody |
|||
| BNC402946-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2946R), CF640R conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2051) Antibody |
|||
| BNC432051-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2051), CF543 conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2051) Antibody |
|||
| BNC432051-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2051), CF543 conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2062) Antibody |
|||
| BNC432062-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2062), CF543 conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2062) Antibody |
|||
| BNC432062-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2062), CF543 conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2085) Antibody |
|||
| BNC432085-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2085), CF543 conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2085) Antibody |
|||
| BNC432085-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2085), CF543 conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2946R) Antibody |
|||
| BNC432946-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2946R), CF543 conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2946R) Antibody |
|||
| BNC432946-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2946R), CF543 conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2051) Antibody |
|||
| BNC052051-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2051), CF405M conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2051) Antibody |
|||
| BNC052051-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2051), CF405M conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2062) Antibody |
|||
| BNC052062-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2062), CF405M conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2062) Antibody |
|||
| BNC052062-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2062), CF405M conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2085) Antibody |
|||
| BNC052085-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2085), CF405M conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2085) Antibody |
|||
| BNC052085-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2085), CF405M conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2946R) Antibody |
|||
| BNC052946-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2946R), CF405M conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2946R) Antibody |
|||
| BNC052946-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2946R), CF405M conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2051) Antibody |
|||
| BNC812051-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2051), CF680R conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2051) Antibody |
|||
| BNC812051-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2051), CF680R conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2062) Antibody |
|||
| BNC812062-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2062), CF680R conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2062) Antibody |
|||
| BNC812062-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2062), CF680R conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2085) Antibody |
|||
| BNC812085-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2085), CF680R conjugate, Concentration: 0.1mg/mL |
|||
TLE1 (Synovial Sarcoma Marker) (TLE1/2085) Antibody |
|||
| BNC812085-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against TLE1 (Synovial Sarcoma Marker) (TLE1/2085), CF680R conjugate, Concentration: 0.1mg/mL |
|||